Voglibose 0.3 mg + Metformin 500 mg is an oral medicine belonging to the category of antidiabetic drugs and is used for the management of type 2 Diabetes mellitus.

More Common  

1. Abdominal or stomach discomfort 
2. Cough or hoarseness 
3. Decreased appetite 
4. Diarrhea 
5. Fast or shallow breathing 
6. Fever or chills 
7. General feeling of discomfort 
8. Lower back or side pain 
9. Muscle pain or cramping 
10. Painful or difficult urination 
11. Sleepiness 

Less Common 

1. Anxiety 
2. Blurred vision 
3. Chest discomfort 
4. Cold sweats 
5. Coma 
6. Confusion 
7. Cool, pale skin 
8. Depression 
9. Difficult or labored breathing 
10. Dizziness 
11. Fast, irregular, pounding, or racing heartbeat or pulse 
12. Feeling of warmth 
13. Headache 
14. Increased hunger 
15. Increased sweating 
16. Nausea 
17. Nervousness 
18. Nightmares 
19. Redness of the face, neck, arms, and occasionally, upper chest 
20. Seizures 
21. Shakiness 
22. Slurred speech 
23. Tightness in the chest 
24. Unusual tiredness or weakness 

This medication works by addressing two core problems in type 2 diabetes: excess glucose production and sharp post-meal sugar spikes. Metformin acts as a metabolic regulator, reducing liver glucose output and improving insulin sensitivity on cells to utilize the sugars for energy, while voglibose slows carbohydrate breakdown and absorption in the small intestine, leading to removal of sugars from the body without entering the liver. This dual action helps stabilize both fasting and postprandial blood sugar levels, supporting better glycemic control without causing hypoglycemia or weight gain.

Pregnancy

The safety of voglibose and metformin in pregnancy is not established. Inform your doctor if you are pregnant or planning to conceive.

Breastfeeding

This medicine can pass into breast milk and lower a baby’s blood sugar, causing weakness, irritability, or confusion. Talk to your doctor about whether to keep breastfeeding or continue the medicine.

Kidney and Liver Problems

Voglibose and metformin are cleared through the liver and kidneys, so in patients with existing kidney and liver problems, these organs may get strained or damaged. Such patients must always consult a doctor before using the medicine.

Avoid alcohol and smoking while on teneligliptin, as they strain the liver and pancreas and can disturb blood sugar control, and may cause rise or fall in blood sugar levels unpredictably

Avoid taking Voglibose and metformin with the following medicines, as it may increase or decrease the desired effect, or in worse cases, it could be fatal:

IUPAC (International Union of Pure and Applied Chemistry)/ Chemical name

Voglibose- (1S,2S,3R,4S,5S)-5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetraol.

Metformin-N, N-dimethylimidodicarbonimidic diamide

Daily dose

Take Voglibose and metformin exactly as your doctor recommends. The dose may change based on your condition and how well you respond. Do not take more than prescribed without consulting your doctor.

Missed Dose

If you forget to take your medicine, take the medication as soon as you remember. If it’s nearly time for your next dose, skip the missed one and continue with your regular schedule. Always consult the doctor before making any changes to your dosage.

Overdose

It is not recommended to take more than 2 mg of Voglibose or 1500 mg of Metformin per day, as overdose may cause drowsiness, confusion, low blood pressure, sweating, gastric distress, or seizures. If symptoms persist, take glucose or sugary foods and seek medical help immediately.

1. Store the medicine at room temperature 
2. Keep away from sunlight and moisture 
3. Keep out of reach of children 

1. Take Voglibose and metformin exactly as prescribed by your doctor, at the same time each day. 
2. Do not stop taking Voglibose and metformin without your doctor’s approval, even if you feel better. 
3. If you forget to take Voglibose and metformin, take them as soon as you remember. If it’s almost time for your next dose, skip the missed dose. 

The voglibose and metformin combination is an oral antidiabetic therapy used in type 2 diabetes, especially for controlling post-meal glucose spikes. Metformin, a biguanide, reduces liver glucose output and improves insulin sensitivity, while voglibose, an alpha-glucosidase inhibitor, delays carbohydrate absorption in the gut, as carbohydrate is a type of sugar, its delay in absorption causes removal of sugar from the body without storing it in the liver. This medicine is taken before meals; they work together to smooth both fasting and postprandial glucose levels. High-fiber meals may enhance voglibose’s effect; alcohol or fatty foods can worsen metformin’s gastrointestinal side effects.

What are the uses of voglibose and metformin hydrochloride tablets?

Voglibose and metformin hydrochloride tablets are used to manage type 2 diabetes by improving blood sugar control. They help reduce both fasting and post-meal glucose levels without causing weight gain or hypoglycemia.

What is the mechanism of action of voglibose and metformin hydrochloride tablets?

Voglibose and metformin hydrochloride tablets work by reducing liver glucose production and improving insulin sensitivity (metformin), while slowing carbohydrate absorption in the intestine to control post meal spikes (voglibose). Together, they stabilize blood sugar levels in type 2 diabetes.

Does metformin cause weight gain?

Metformin is not usually linked to weight gain; in fact, it often helps with modest weight loss or weight stability by improving insulin sensitivity. Rarely, some people may notice weight gain due to factors like fluid retention, increased appetite, or lifestyle influences.

Which class does metformin belong to?

Metformin belongs to the class of biguanides used to treat diabetes and control blood sugar levels.

1. Bailey CJ. Metformin: effects on micro and macrovascular complications in type 2 diabetes. Br J Diabetes Vasc Dis. 2008;8(3):121–7. Available from. 
2. Drugs.com. Voglibose [Internet]. Drugs.com International. [cited 2025 Aug 14]. Available from. 
3. DrugBank Online. Voglibose [Internet]. Edmonton (AB): DrugBank; [cited 2025 Aug 14]. Available from. 
4. Kumar V, Abbas AK, Aster JC. Robbins Basic Pathology. 10th ed. Philadelphia: Elsevier; 2017. Chapter 25, The Endocrine System [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); [cited 2025 Aug 14]. Available from. 
5. Stat Pearls [Internet]. Treasure Island (FL): Stat Pearls Publishing; 2024 Jan–. Available from. 
6. Drug Bank. Metformin [Internet]. Edmonton (AB): Drug Bank; [cited 2025 Jul 18]. Available from. 
7. WebMD. Metformin oral [Internet]. New York (NY): WebMD LLC; ©1996–2025 [cited 2025 Jul 18]. Available from. 
8. Drugs.com. Metformin [Internet]. ©1996–2025 [cited 2025 Jul 18]. Available from.